ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Should Surgery Be First-Line Treatment for Head and Neck Cancer?

by Margot J. Fromer • March 1, 2009

  • Tweet
  • Email
Print-Friendly Version

Head and neck cancer specialists are increasingly advocating surgery alone-or at least as first-line treatment. Often, patients with small tumors, and even some with larger ones, can avoid the well-known and significantly life-altering toxicity of chemoradiation.

You Might Also Like

  • Is Speech Language Pathologist Evaluation Necessary in the Non-Operative Treatment of Head and Neck Cancer?
  • Induction Chemo May Be Superior to Chemoradiotherapy Alone in Unresectable Head And Neck Cancer
  • Targeted Therapy a Potential Treatment for Head and Neck Cancer
  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?
Explore This Issue
March 2009

Is this a reasonable clinical idea? It’s a huge question, said Jonas T. Johnson, MD, Chairman of the Department of Otolaryngology at University of Pittsburgh School of Medicine.

Christine Gourin, MD, Associate Professor and Director of the Clinical Research Program in Head and Neck Cancer at Johns Hopkins School of Medicine in Baltimore, agreed. The major determinants of whether surgery is an effective treatment are histology and stage. If the tumor is low-grade and/or early-stage, surgery alone can be curative, she said.

Bruce T. Haughey, MBChBFor small tumors, surgery is very efficient and cost-effective, and it allows patients to get back to their usual lives faster than with chemoradiation. Surgery carries few lingering after-effects, and there are lots of arguments in its favor.

-Bruce T. Haughey, MBChB

Bruce H. Haughey, MBChB, Kimbrough Professor of Otolaryngology-Head and Neck Surgery and Director of the Head and Neck Cancer Center at Washington University School of Medicine in St. Louis, added that this is a serious debate. For small tumors, surgery is very efficient and cost-effective, and it allows patients to get back to their usual lives faster than with chemoradiation. Surgery carries few lingering after-effects, and there are lots of arguments in its favor.

In a Nutshell

We never give chemotherapy or chemoradiation (CRT) for stage 1 or stage 2 disease, simply because it is not required, said Dr. Johnson. The biologic costs are too great, and there are no data to show that chemo provides a benefit in early-stage disease. It’s just too much treatment.

For example, in some patients, endoscopic resection of the larynx, which can be done on an outpatient basis, is more effective and efficient than six weeks of radiation.

Dr. Gourin agreed with him about early laryngeal cancer but warned that all head and neck cancer patients have a high lifelong risk of second such cancers. The ability to hold radiation in reserve for the future is a huge potential benefit of primary surgery for early-stage cancer, she noted.

But what about patients who want chemo and/or radiation after surgery to destroy micrometastases? Dr. Johnson replied, Currently, we have no way to find metastatic disease before it becomes detectable, so there’s no point in giving highly toxic drugs for the very unlikely event of distant metastasis. Thus, only patients with advanced tumors should be offered adjuvant CRT.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Everyday Ethics, Head and Neck Issue: March 2009

You Might Also Like:

  • Is Speech Language Pathologist Evaluation Necessary in the Non-Operative Treatment of Head and Neck Cancer?
  • Induction Chemo May Be Superior to Chemoradiotherapy Alone in Unresectable Head And Neck Cancer
  • Targeted Therapy a Potential Treatment for Head and Neck Cancer
  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Otolaryngologists Have a Major Role to Play in Treating COVID-19 Long-Haulers
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.